about
Metalloprotein-based MRI probesIs there a path beyond BOLD? Molecular imaging of brain functionBiodegradable, polymer encapsulated, metal oxide particles for MRI-based cell trackingDynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis.Magnetosomes, biogenic magnetic nanomaterials for brain molecular imaging with 17.2 T MRI scanner.Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives.MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritisCompact Ag@Fe3O4 core-shell nanoparticles by means of single-step thermal decomposition reaction.Molecular magnetic resonance contrast agents for the detection of cancer: past and present.Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging.Semi-automated 3D segmentation of major tracts in the rat brain: comparing DTI with standard histological methodsBiodistribution of newly synthesized PHEA-based polymer-coated SPION in Sprague Dawley rats as magnetic resonance contrast agentAn approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.Engineered nanoparticles for biomolecular imaging.Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agentMagnetic resonance relaxation induced by superparamagnetic particles used as contrast agents in magnetic resonance imaging: a theoretical review.Iron oxide magnetic nanoparticles as antimicrobials for therapeutics.Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody.Externally Applied Static Magnetic Field Enhances Cardiac Retention and Functional Benefit of Magnetically Iron-Labeled Adipose-Derived Stem Cells in Infarcted Hearts.Assessment of inflammation with a very small iron-oxide particle in a murine model of reperfused myocardial infarction.Hindered diffusion of MRI contrast agents in rat brain extracellular micro-environment assessed by acquisition of dynamic T1 and T2 maps.
P2860
Q26849668-35671810-ABDA-4EA2-B599-BF682FB33D52Q27013829-EB03ECCE-5DA8-4497-BA21-364FB6C2E9D4Q27025163-F3761697-5310-45B8-A040-EB65BD849D9AQ30448699-33AFC82A-58DE-4C32-9CF8-77231EBE526DQ30891547-3F752AFC-E13B-4ED5-A917-BA022ADE93F2Q31934521-D7DA8B6A-17C9-458B-9854-084A756D1451Q33678501-68AE4941-C9BD-44C1-AF6D-6E3AB155ACFEQ34146129-5E9074CD-28A5-4113-BC2E-0F9364375FAEQ34424355-6B48C5C4-F923-474B-BE46-B047D9725EC2Q34823410-A17D39F9-532F-486C-8AAC-B51DF32A3134Q36202879-3EE697B9-B4B1-43B6-A4EB-221E74743214Q36614855-F18AB5DE-B288-499F-A66E-87FF01CC6AB2Q36776839-1AC2D0E2-1900-4BB1-8389-53A6CC01D0ACQ37273871-5E148BB8-1ED6-47FD-92B8-E94FA5042C03Q37278614-85EEBB59-631E-45BE-8807-28B380446870Q37626229-778B4FB9-C33C-4AD5-B1D3-7880860EACD4Q37668307-58B74236-2EF1-4677-BE36-6EFA2665270BQ37895953-068882F2-F610-485D-A90C-5962EFBC6135Q38559085-C5187972-DAFF-4835-B6DC-EACDBEAFF168Q38842822-3712E564-F860-419A-9BB5-0CB760720472Q39342006-AD0D325A-8EFB-4377-8277-351488D77621Q41065057-AA493EFB-02F8-4964-940C-8CBCEFCF533FQ41657655-6C1C273B-B897-4C8C-BC42-CB140A48A9E9Q44629222-EDB8C6AE-0008-457F-B690-94C3BEEB0326Q45348184-DBAB4F7D-756E-4B2E-9C49-EF027940B187
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Ferromagnetic contrast agents: a new approach.
@ast
Ferromagnetic contrast agents: a new approach.
@en
type
label
Ferromagnetic contrast agents: a new approach.
@ast
Ferromagnetic contrast agents: a new approach.
@en
prefLabel
Ferromagnetic contrast agents: a new approach.
@ast
Ferromagnetic contrast agents: a new approach.
@en
P2093
P356
P1476
Ferromagnetic contrast agents: a new approach.
@en
P2093
A C McLaughlin
P F Renshaw
P304
P356
10.1002/MRM.1910030205
P577
1986-04-01T00:00:00Z